Figure legends
Figure 1 Disease severity, viral load, and viral duration in WH
and NWH patients. (A) Disease severity distribution of the two groups
during hospitalization. (B) Viral load at hospital admission and midterm
in WH and NWH patients. (C) Viral duration in WH and NWH patients. The
viral duration was determined as the time from patient’s exposure to
other confirmed patients until his/her viral nucleic acid test was
negative. The data are expressed as the median and IQR. An unpaired t
test was used, and P<0.05 was considered significant.
Figure 2 T cell count in peripheral blood from WH and NWH
patients. (A) CD3+ T cell count in peripheral
blood/μL. (B) CD4+ T cell count in peripheral
blood/μL. (C) CD8+ T cell count in peripheral
blood/μL. The data are expressed as the median and IQR. An unpaired t
test was used, and P<0.05 was considered significant.
Supplemental Figure 1 Pulmonary function in WH and NWH patients
at different time points . (A) pH. (B) Partial pressure of oxygen (PO2),
mmHg. (C) Partial pressure of carbon dioxide(PCO2), mmHg. (D) Fraction
of inspiration O2(FIO2), %. (E) Oxygenation index(OI), mmHg. The data
are expressed as the median and IQR. An unpaired t test was used, and
P<0.05 was considered significant.
Supplemental Figure 2 Hepatic function in WH and NWH patients at
different time points. (A) Total bilirubin(TBil), μmol/L. (B) Direct
bilirubin(DBil), μmol/L. (C) Alanine aminotransferase(ALT), U/L. (D)
Glutamic oxalacetic transaminase(AST), U/L. (E) Lactic
dehydrogenase(LDH), U/L. (F) Blood urea nitrogen(BUN), mmol/L. (G)
Creatinine(Crea), μmol/L. The data are expressed as the median and IQR.
An unpaired t test was used, and P<0.05 was considered
significant.
Supplemental Figure 3 Blood coagulation function in WH and NWH
patients at different time points. (A) plasma prothrombin time(PT), s.
(B) activated partial thrombin(APTT), s. (C) Fibrinogen(FIB), g/L. (D)
D-Dimer, μg/mL. The data are expressed as the median and IQR.
An unpaired t test was used, and P<0.05 was considered
significant.
Supplemental Figure 4 Inflammatory indicators in WH and NWH
patients at different time points. (A) Procalcitonin (PCT), ng/mL. (B)
C reactive protein(CRP), mg/L. (C) Interleukin-6(IL-6), pg/mL. The data
are expressed as the median and IQR. An unpaired t test was used, and
P<0.05 was considered significant.
Supplemental Figure 5 Hemogram in WH and NWH patients at
different time points . (A) White blood cell count(WBC),
*109/L. (B) Lymphocyte count(Lymph),
*109/L. (C) Neutrophil count(Neut),
*109/L. (D) Eosinophils count,
*109/L. (E) haemoglobin(Hgb), g/L. (F) platelet
count(PLT), *109/L. (F) Albumin(ALB), g/L. The data
are expressed as the median and IQR. An unpaired t test was used, and
P<0.05 was considered significant.